| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 05/24/2011 | US7947439 Detection of bovine viral diarrhea virus in tissue samples |
| 05/24/2011 | CA2227860C Avirulent herpetic viruses useful as tumoricidal agents and vaccines |
| 05/19/2011 | WO2011058081A2 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides |
| 05/19/2011 | WO2011014416A3 High yield yellow fever virus strain with increased propagation in cells |
| 05/19/2011 | US20110118334 Antisense antiviral compound and method for treating influenza viral infection |
| 05/19/2011 | US20110117628 Method for concentrating and isolating biomolecules or viruses |
| 05/19/2011 | US20110117627 Regulation of apoptosis by neural specific splice variants of ig20 |
| 05/19/2011 | US20110117126 Attenuated pestivirus |
| 05/19/2011 | US20110114244 Self-assembly of macromolecules on multilayered polymer surfaces |
| 05/19/2011 | DE102010038034A1 Reinigungsverfahren und Verfahren zum Herstellen von Impfstoff Purification process and method for preparing vaccine |
| 05/18/2011 | EP2322609A1 Hcv/gbv-b chimeric virus |
| 05/18/2011 | CN1958788B Gene recombined virus of human neurenergen 3 |
| 05/18/2011 | CN102066407A Novel avian astrovirus |
| 05/18/2011 | CN102061288A Molecular antigen arrays using a virus like particle derived from the AP205 coat protein |
| 05/18/2011 | CN102060915A Modifiable loca of human type 3 adenovirus hexon and application thereof |
| 05/18/2011 | CN102058882A Method of preparing hepatitis A inactivated vaccine |
| 05/18/2011 | CN101358204B Method for preparing cellular membrane and cellular organelle membrane protein after human enveloped virus budding |
| 05/18/2011 | CN101123871B Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
| 05/18/2011 | CN101012455B Deactivation method of biochemistry substance, preparing method of cardiomyopeptidin and use of cardiomyopeptidin |
| 05/17/2011 | USRE42373 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/17/2011 | US7943379 Production of rAAV in vero cells using particular adenovirus helpers |
| 05/17/2011 | US7943375 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 05/17/2011 | US7943149 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | US7943140 Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1 |
| 05/17/2011 | US7943134 Compositions and methods for identifying response targets and treating flavivirus infection responses |
| 05/12/2011 | WO2011056993A1 Compositions and methods for treating cancer with attenuated oncolytic viruses |
| 05/12/2011 | WO2011056591A1 High titer recombinant influenza viruses with enhanced replication in vero cells |
| 05/12/2011 | WO2011056148A1 Muteins of the bacteriophage lambda integrases |
| 05/12/2011 | WO2011033005A3 Cells for transient expression and uses thereof |
| 05/12/2011 | US20110112503 Chemistrode, a plug-based microfluidic device and method for stimulation and sampling with high temporal, spatial, and chemical resolution |
| 05/12/2011 | US20110112279 Compositions and Methods Relating to STOP-1 |
| 05/12/2011 | US20110111480 Telomelysin/GFP-expressing recombinant virus |
| 05/12/2011 | US20110111391 Newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |
| 05/12/2011 | US20110110978 High titer recombinant influenza viruses with enhanced replication in vero cells |
| 05/12/2011 | US20110110975 Inactivated virus compositions and methods of preparing such compositions |
| 05/12/2011 | US20110110892 Vectors for delivering disease neutralizing agents |
| 05/12/2011 | US20110110887 Recombinant herpesvirus of turkeys encoding for interleukin-12 |
| 05/12/2011 | CA2816401A1 Generation of antigenic virus-like particles through protein-protein linkages |
| 05/12/2011 | CA2779645A1 Vaccines for the treatment of neoplasias based on viral capsids of birnavirus containing human papillomavirus antigens |
| 05/12/2011 | CA2779632A1 Simian adenovirus and methods of use |
| 05/11/2011 | EP2319918A1 Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319916A1 Cell capable of replicating novel hcv replicon, cell capable of replicating full-length hcv rna, and use of those cells |
| 05/11/2011 | EP2319532A1 Recombinant dengue virus containing a common 30 nucleotide deletion in the 3'-UTR of dengue types 3, or 4 |
| 05/11/2011 | EP2318530A1 New influenza virus immunizing epitope |
| 05/11/2011 | EP2318043A2 Influenza hemagglutinin and neuraminidase variants |
| 05/11/2011 | EP1456398B1 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna |
| 05/11/2011 | EP1381280B1 Viral vectors and their use in therapeutic methods |
| 05/11/2011 | CN1942585B Nucleic acid construct containing full-length genome of human hepatitis c virus, method for nucleic acid construct transferring into recombinant full-length virus genome replicative cell and method of producing hepatitis C virus particle |
| 05/11/2011 | CN1890366B Isolated phages and their use as disinfectant in food or for sanitation of factory environment |
| 05/11/2011 | CN1692156B Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 05/11/2011 | CN1599623B Packaging of immunostimulatory substances into virus-like particles: method of preparation and use |
| 05/11/2011 | CN102051379A Recombinant herpes simplex virus (HSV) genetic operation system and application thereof |
| 05/11/2011 | CN102051358A Mosaic tumor specific gene expression regulation kit and application thereof |
| 05/11/2011 | CN102051347A Concentration method of virus in seawater and measurement method of virus concentration recovery |
| 05/11/2011 | CN102051346A Concentration method of virus in marine shellfish and measurement method of virus concentration recovery |
| 05/11/2011 | CN101372685B Constructing method for recombinant baculovirus |
| 05/11/2011 | CN101353647B Simulating retrovirus of target tumor, and preparation and use thereof |
| 05/10/2011 | US7939326 Methods and compositions for enhancing cell adhesion properties |
| 05/10/2011 | US7939318 Flexible vaccine assembly and vaccine delivery platform |
| 05/10/2011 | US7939086 Modified Vaccinia Ankara virus variant |
| 05/10/2011 | US7939085 Attenuated myxomavirus that has lost receptor properties of myxomavirus interferon receptor or myxomavirus tumor necrosis factor receptor or myxomavirus interleukin receptor; causes an increase in number of leukocytes in human patient 7 days after administration |
| 05/10/2011 | US7939082 Papilloma virus vaccine |
| 05/10/2011 | CA2459754C Vaccinia virus mva-e3l-knock-out-mutants and use thereof |
| 05/10/2011 | CA2295858C Rhabdoviruses with reengineered coats |
| 05/10/2011 | CA2165458C Intracellular binding proteins and use thereof |
| 05/05/2011 | WO2011052735A1 Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same |
| 05/05/2011 | US20110105423 Compounds that modulate negative-sense, single-stranded rna virus replication and uses thereof |
| 05/05/2011 | US20110105362 Cyanine compounds and their application as quenching compounds |
| 05/05/2011 | US20110104789 Non-integrating rev-dependent lentiviral vector and methods of using the same |
| 05/05/2011 | US20110104788 Modulation of Adenoviral Tropism |
| 05/05/2011 | US20110104756 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | US20110104201 Porcine Reproductive and Respiratory Syndrome Vaccine Based on Isolate JA-142 |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104191 Malva mosaic virus and virus-like particles and uses thereof |
| 05/05/2011 | US20110104178 Novel avian astrovirus |
| 05/05/2011 | US20110104130 Thymidylate kinase fusions and uses thereof |
| 05/05/2011 | US20110104120 Directed Evolution and In Vivo Panning of Virus Vectors |
| 05/05/2011 | US20110104117 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 05/05/2011 | US20110104105 Vaccines and immunotherapeutics using il-28 and compositions and methods of using the same |
| 05/05/2011 | CA2778568A1 Antibody having activity of inhibiting hepatitis c virus (hcv) infection and use thereof |
| 05/04/2011 | EP2316925A1 Circovirus sequences associated with porcine wasting disease (PWD) |
| 05/04/2011 | EP2316924A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316923A2 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 05/04/2011 | EP2316480A1 Chimeric tymovirus-like particles |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | EP1802746B1 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 05/04/2011 | EP1456228B1 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/04/2011 | CN102046790A Recombinant virus, escherichia coli retaining the same and a process for production thereof |
| 05/04/2011 | CN102041272A Slow virus-mediated pig growth hormone single plasmid induced expression system |
| 05/04/2011 | CN102041247A Salmonella bacteriophage and application thereof |
| 05/04/2011 | CN102041246A Human embryo retina transformed cell line for producing biological products |
| 05/04/2011 | CN102040658A Schistosoma japonica polypeptide with immunogenicity and application thereof |
| 05/04/2011 | CN102038947A Method for industrially producing animal rabies vaccine by utilizing bioreactor |
| 05/04/2011 | CN102038946A Method for industrially producing pseudorabies vaccine by using bioreactor |
| 05/04/2011 | CN102038945A Method for industrially producing swine parvovirus vaccine by utilizing bioreactor |
| 05/04/2011 | CN102038944A Method for industrially producing swine fever live vaccine by using bioreactor |
| 05/04/2011 | CN102038943A Method for industrially producing porcine Japanese encephalitis (JE) vaccines by utilizing bioreactor |
| 05/04/2011 | CN102038942A Method for industrially producing porcine reproductive and respiratory syndrome (PRRS) vaccines by utilizing bioreactor |